Treatment of renal osteodystrophy with 1α-hydroxycholecalciferol (1α-OH-D3) in conjunction with a high dialysate calcium
- 1 December 1976
- journal article
- case report
- Published by Springer Nature in Calcified Tissue International
- Vol. 22 (S1) , 94-100
- https://doi.org/10.1007/bf02064047
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- VARIABLE RESPONSE TO LONG-TERM 1α-HYDROXYCHOLECALCIFEROL IN HÆMODIALYSIS OSTEODYSTROPHYThe Lancet, 1976
- CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1976
- 1α-hydroxycholecalciferol and 25-hydroxycholecalciferol in Renal Bone DiseasePublished by Springer Nature ,1976
- Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysisKidney International, 1975
- The kidney as an endocrine organ involved in the function of vitamin DThe American Journal of Medicine, 1975
- 1-ALPHA-HYDROXYCHOLECALCIFEROL AS A SUBSTITUTE FOR THE KIDNEY HORMONE 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1973
- Total body calcium and long-term calcium balance in chronic renal disease.1973
- Azotaemic renal osteodystrophy: a quantitative study on iliac boneJournal of Clinical Pathology, 1973
- Control of secondary hyperparathyroidism during long-term hemodialysisThe American Journal of Medicine, 1971